Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126

Adagene Inc. ("Adagene") (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced data from its ...

Related Keywords

San Francisco ,California ,United States ,Australia ,Singapore ,China ,Antara ,Aceh ,Indonesia ,Suzhou ,Jiangsu ,Japan ,San Diego ,American ,Heinz Josef Lenz ,Daneng Li ,Nasdaq ,Adagene Inc ,Merck Co Inc ,Clinical Research ,Twitter ,City Of Hope Comprehensive Cancer Center ,Merck Sharp Dohme ,American Society Of Clinical Oncology ,Norris Comprehensive Cancer Center ,European Union ,Dynamic Precision Library ,Exchange Commission ,Translational Science Program ,Professor Department Of Medical Oncology Therapeutics Research ,Linkedin ,American Society ,Clinical Oncology ,Cancers Symposium ,Associate Professor Department ,Medical Oncology ,Therapeutics Research ,Hope Comprehensive Cancer ,Associate Director ,Comprehensive Cancer Center ,Merck Sharp ,